PGIM Investments reviews Q2 2025 Target Date Fund performance, spotlighting equity gains, bond trends, and asset allocation.

In a study, which findings have been published in the Journal of the American Medical Directors Association, the scoring ...

Palantir has been one of the hottest stocks in global markets. Yet, many still can’t grasp what it does let alone agree on ...

Gross margin rose to 44.9% in Q4 FY2025, up 6.1 percentage points from the same period in fiscal 2024. Net sales growth remained sluggish, with revenue up just 1% from the prior year period. Farmer ...